dc.contributor.author | ADELUNG, Rainer | |
dc.date.accessioned | 2020-05-12T13:30:40Z | |
dc.date.available | 2020-05-12T13:30:40Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | ADELUNG, Rainer. Oxide Semiconductors as Antiviral Agents: Herpes Therapy from Lab to Pharmacy. In: ICNMBE: International conference on Nanotechnologies and Biomedical Engineering: proc. of the 3rd intern. conf., Sept. 23-26 : Program & Abstract Book , 2015. Chişinău, 2015, p. 46. | en_US |
dc.identifier.uri | http://repository.utm.md/handle/5014/8148 | |
dc.description | Abstract | en_US |
dc.description.abstract | Herpes simplex viruses (HSV) establish lifelong infections, and the virus cannot yet be eradicated from the body. The HSV-2 type is one of the most frequent sexually transmitted infections worldwide with global estimates of 536 million infected people and an annual incidence of 23.6 million cases [1]. In this presentation, the antiviral potential of oxide semiconductors as antiviral agents will be discussed [2-4]. Oxygen vacancies are employed as adhesion sites of glycoproteins on the surface of the capsid and bind the virus effectively. It will be shown that oxid semiconductors can have a prophylactic, therapeutic as well as neutralizing effect. It will be explained how irradiation of UV-light can even increase the antiviral activity. | en_US |
dc.publisher | Tehnica UTM | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | viruses | en_US |
dc.subject | herpes simplex viruses | en_US |
dc.subject | oxide semiconductors | en_US |
dc.subject | semiconductors | en_US |
dc.title | Oxide Semiconductors as Antiviral Agents: Herpes Therapy from Lab to Pharmacy | en_US |
dc.type | Article | en_US |
The following license files are associated with this item: